Grant: Master's Award: Canada Graduate Scholarships
McGill University
$17,500.00
The Association of Parkinson's disease and Genetic Variation in Nicotine-Related Genes investigated by Molecular Inversion Probe Sequencing
FY 2015-16
Summary
Parkinson's disease (PD) is a neurodegenerative disease that affects a significant proportion of the elderly population. Significant motor and cognitive function decline can occur, and despite years of study there remains no cure and few treatments. One of the less-studied aspects of the disease is that cigarette smoking has an association with the risk of developing the disease. Patients are less likely to have previously smoked, and smokers have a significantly lower risk of developing PD. The biological reason for this association is not completely understood. The acetylcholine neurotransmitter network in the brain often displays damage during PD pathology; the same network is impacted by the use of nicotine. Further, previous studies have suggested a role of acetylcholine receptor genes in the risk of developing PD. The hypothesis of this study is that the nicotine use is genetically related to the systems damaged in PD pathology. Patients may carry mutations within nicotine-related genes, and these mutations could be risk factors or causative for PD. The proposed study will sequence acetylcholine receptor genes that are affected by nicotine, as well as genes responsible for biochemical metabolism of nicotine. Patients and unaffected controls from Quebec and France will be genetically analysed using Molecular Inversion Probe sequencing, a recently described method that allows for a large number of genes and samples to be investigated at the same time. This research will help better understand the genetic susceptibility to PD, as well as inform future treatment and prevention of the disease.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
349970
Name
Ross Jay
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
The Association of Parkinson's disease and Genetic Variation in Nicotine-Related Genes investigated by Molecular Inversion Probe Sequencing
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Aging; Brain; Genetics; Movement Disorder; Mutation; Neurodegeneration; Neurotransmitters; Nicotine; Parkinson'S Disease; Sequencing
Abstract
Parkinson's disease (PD) is a neurodegenerative disease that affects a significant proportion of the elderly population. Significant motor and cognitive function decline can occur, and despite years of study there remains no cure and few treatments. One of the less-studied aspects of the disease is that cigarette smoking has an association with the risk of developing the disease. Patients are less likely to have previously smoked, and smokers have a significantly lower risk of developing PD. The biological reason for this association is not completely understood. The acetylcholine neurotransmitter network in the brain often displays damage during PD pathology; the same network is impacted by the use of nicotine. Further, previous studies have suggested a role of acetylcholine receptor genes in the risk of developing PD. The hypothesis of this study is that the nicotine use is genetically related to the systems damaged in PD pathology. Patients may carry mutations within nicotine-related genes, and these mutations could be risk factors or causative for PD. The proposed study will sequence acetylcholine receptor genes that are affected by nicotine, as well as genes responsible for biochemical metabolism of nicotine. Patients and unaffected controls from Quebec and France will be genetically analysed using Molecular Inversion Probe sequencing, a recently described method that allows for a large number of genes and samples to be investigated at the same time. This research will help better understand the genetic susceptibility to PD, as well as inform future treatment and prevention of the disease.
Competitiondate
201512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Ross, Jay
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~